ZA933567B - Use of (E)-2-(p-fluorophenethyl)-3-fluoroallylamine in the treatment of Alzheimer's disease - Google Patents

Use of (E)-2-(p-fluorophenethyl)-3-fluoroallylamine in the treatment of Alzheimer's disease

Info

Publication number
ZA933567B
ZA933567B ZA933567A ZA933567A ZA933567B ZA 933567 B ZA933567 B ZA 933567B ZA 933567 A ZA933567 A ZA 933567A ZA 933567 A ZA933567 A ZA 933567A ZA 933567 B ZA933567 B ZA 933567B
Authority
ZA
South Africa
Prior art keywords
fluoroallylamine
fluorophenethyl
alzheimer
disease
treatment
Prior art date
Application number
ZA933567A
Other languages
English (en)
Inventor
Ian A Mcdonald
Michael G Palfreyman
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA933567B publication Critical patent/ZA933567B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA933567A 1992-05-27 1993-05-21 Use of (E)-2-(p-fluorophenethyl)-3-fluoroallylamine in the treatment of Alzheimer's disease ZA933567B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88867192A 1992-05-27 1992-05-27

Publications (1)

Publication Number Publication Date
ZA933567B true ZA933567B (en) 1993-12-13

Family

ID=25393634

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA933567A ZA933567B (en) 1992-05-27 1993-05-21 Use of (E)-2-(p-fluorophenethyl)-3-fluoroallylamine in the treatment of Alzheimer's disease

Country Status (15)

Country Link
EP (1) EP0642338B1 (ja)
JP (1) JPH07507299A (ja)
KR (1) KR950701518A (ja)
AT (1) ATE147978T1 (ja)
AU (1) AU672401B2 (ja)
CA (1) CA2135752C (ja)
DE (1) DE69307702T2 (ja)
DK (1) DK0642338T3 (ja)
ES (1) ES2101311T3 (ja)
GR (1) GR3022608T3 (ja)
HU (1) HUT72316A (ja)
MX (1) MX9303074A (ja)
NO (1) NO944524L (ja)
WO (1) WO1993024120A1 (ja)
ZA (1) ZA933567B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09505276A (ja) * 1993-09-24 1997-05-27 メレルファーマスーティカルズ インコーポレイテッド (E)−2−(p−フルオロフェネチル)−3−フルオロアリルアミンを含有するトランスダーマルデバイス、およびアルツハイマー病の処置に於けるその使用方法
US5488188A (en) * 1994-09-29 1996-01-30 Merrell Dow Pharmaceuticals Inc. Process for the preparation of (E)-1-amino-2-(fluoromethylene)-4-(p-fluorophenyl)butane, novel processes for preparing an intermediate thereof, and novel intermediates thereof
US5599986A (en) * 1994-09-29 1997-02-04 Hoechst Marion Roussel Inc. Process for the preparation of alkali metal salts of diformylamide
US20070293548A1 (en) * 2006-03-31 2007-12-20 Wang Eric Y Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases
EP1870097A1 (en) * 2006-06-15 2007-12-26 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful in the treatment of cognitive disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ224982A (en) * 1987-06-16 1990-08-28 Merrell Dow Pharma E-2-(p-fluorophenethyl)-3-fluoroallylamine and its pharmaceutical compositions

Also Published As

Publication number Publication date
GR3022608T3 (en) 1997-05-31
DK0642338T3 (da) 1997-02-10
WO1993024120A1 (en) 1993-12-09
DE69307702T2 (de) 1997-05-28
HU9403384D0 (en) 1995-02-28
ATE147978T1 (de) 1997-02-15
AU672401B2 (en) 1996-10-03
CA2135752A1 (en) 1993-12-09
EP0642338A1 (en) 1995-03-15
DE69307702D1 (de) 1997-03-06
JPH07507299A (ja) 1995-08-10
EP0642338B1 (en) 1997-01-22
AU3978293A (en) 1993-12-30
ES2101311T3 (es) 1997-07-01
NO944524D0 (no) 1994-11-25
KR950701518A (ko) 1995-04-28
NO944524L (no) 1994-11-25
HUT72316A (en) 1996-04-29
MX9303074A (es) 1994-01-31
CA2135752C (en) 1998-07-14

Similar Documents

Publication Publication Date Title
EP0735870A4 (en) USE OF PHOSPHOLIPASE-A2 INHIBITORS FOR TREATING ALZHEIMER'S DISEASE
GR3029670T3 (en) Treatment of macular degeneration.
HK1003978A1 (en) Composition for the treatment of schizophrenia
GB2285219A (en) Use of norastemizole for the treatment of allergic disorders
MY118526A (en) Method for improving the pharmacokinetics of tipranavir
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
ES2136167T3 (es) Composiciones de idebenona para tratar la enfermedad de alzheimer.
PL338673A1 (en) Application of fanquinone in treating alzheimer disease
IL117695A0 (en) Pharmaceutical agents for the treatment of alzheimer's disease
ZA933567B (en) Use of (E)-2-(p-fluorophenethyl)-3-fluoroallylamine in the treatment of Alzheimer's disease
NO961180L (no) Transdermal anordning inneholdende (E)-2-(p-fluorfenetyl)-3-fluorallylamin for behandling av Alzheimers sykdom
GR3036260T3 (en) Use of olanzapine for the manufacture of a medicament for the treatment of cerebral focal ischemia
FI953725A (fi) Ornitiiniaminotransferaasi-inhibiittorien käyttö lääkeaineen valmistamiseksi Alzheimerin taudin hoitamiseksi
LV5179A3 (lv) Preparats "etoksidins" teju kunga un zarnu slimibu profilaksei un arstesanai
GB9010389D0 (en) Pharmaceutical formulations for the treatment of peripheral vascular diseases
SI0664121T1 (en) Use of raloxifene and its analogs for the manufacture of a medicament for the treatment of atherosclerose and ischaemic heart disease